The medication for the treatment of liver diseases and biliary tract :: Consumers survey results of for 2 quarter of 2018

Consumers survey results of for 2 quarter of 2018 in category

Digestive system and hepatology / The medication for the treatment of liver diseases and biliary tract

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Essentiale Forte N (Sanofi)	42.86%	5

2.	5	Hepabene (ratiopharm)	38.10%	4.44

3.	2	Карсил (Sopharma)	28.57%	3.33

3.	1	Холосас (Vitaminy)	28.57%	3.33

5.	3	Алохол (Борщагівський ХФЗ)	23.81%	2.78

6.	4	Antralum (Farmak)	19.05%	2.22

7.	5	Галстена (Perrigo)	14.29%	1.67

7.	4	Дарсіл (Darnitsa)	14.29%	1.67

9.	5	Артіхол (Київський вітамінний завод)	9.52%	1.11

9.	~	ГепациалєThe products of TM “Гепациалє” is not a medications. This is a dietary supplement, a cosmetic, or other kind of non-pharmaceutical products.');return false;"> (Ilan Pharm)	9.52%	1.11

9.	4	Енерлів (Berlin-Chemie Menarini)	9.52%	1.11

9.	~	Лів.52 (Фірма ТК Комфорт)	9.52%	1.11

9.	~	Ліволін Форте (Mega Lifesciences)	9.52%	1.11

9.	~	Силібор (Pharmaceutical company “Zdorovya”)	9.52%	1.11

15.	~	Betargin (PharmUnion)	4.76%	0.56

15.	5	Chophytol (Lab. Rosa-Phytopharma)	4.76%	0.56

15.	5	Берези бруньки (Ternopharm)	4.76%	0.56

15.	~	Лів-Кер (Progress pharma)	4.76%	0.56

15.	~	Нукс Воміка (Heel)	4.76%	0.56

15.	5	Холагол (Teva)	4.76%	0.56

15.	~	Холензим (Біосинтез)	4.76%	0.56

–.		Febichol (Noventis)	0.00%	0

–.		Raphacholin C (Herbapol)	0.00%	0

–.		Бренціале Форте (Бринцалов-А)	0.00%	0

–.		Гепа-Мерц (Merz Pharmaceuticals)	0.00%	0

–.		Гепавал (Валартін Фарма)	0.00%	0

–.		Гепатофіт (Aim)	0.00%	0

–.		Глутаргін (Pharmaceutical company “Zdorovya”)	0.00%	0

–.		Есслівер Форте (Stada)	0.00%	0

–.		Левасіл (Micro Labs)	0.00%	0

–.		Легалон (Madaus)	0.00%	0

–.		ПМ Сірін (N. Kapharma Pharmaceuticals)	0.00%	0

–.		Силімарол (Євролек)	0.00%	0

–.		Симепар (Teva)	0.00%	0

–.		Фламін (Arterium Corporation)	0.00%	0

–.		Фосфоліп (Universal Medicare)	0.00%	0

–.		Холівер (Hau Giang Ph. JSK-HG Pharm)	0.00%	0

–.		Холе-гран (Національна гомеопатична спілка)	0.00%	0

–.		Холензим (Belmedpreparaty)	0.00%	0

–.		Цінарікс (Montavit)	0.00%	0

–.	5	Цитраргінін (Zambon France)	0.00%	0

–.		~~Бонджигар (Herbion)~~	~~0.00%~~	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2018, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.